Clinical Trial Update: Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating photodynamic therapy with aminolevulinic acid for oral leukoplakia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Leukoplakia

Drugs mentioned

• Aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Oral Leukoplakia | Phase 1 | Status: TERMINATED